Health System and Patient Factors Facilitating the Implementation of Isoniazid Preventive Therapy for People living with HIV attending Care and Treatment Centres in Songea Municipality, Tanzania
Abstract
Abstract Isoniazid Preventive Therapy (IPT) is an essential public health intervention for people living with HIV (PLHIV), especially in low-income countries with high tuberculosis (TB) and HIV burden. Despite available evidence that IPT is efficacious, its implementation is still low in many countries. Therefore, this study aimed to determine the coverage of IPT implementation and explore factors facilitating the implementation of IPT in Songea municipality, Tanzania. The study employed a cross-sectional descriptive study design using both quantitative and qualitative approaches of data collection. A review of 2148 records of PLHIV eligible for IPT was done to determine coverage of IPT implementation. 21 in-depth interviews and 5 observations were conducted to explore factors facilitating IPT implementation. Overall,IPT coverage of the municipality was estimated to be 45%. The study revealed that the availability of IPT training, regular supportive supervision, collaboration between TB and HIV programs, availability of IPT guidelines and patient registers were the main factors facilitating the implementation of IPT. The study recommends that local government authorities, managements of healthcare facilities, drug suppliers, and partners working in TB and HIV programs, service providers, community leaders and community health workers should continue working together and ensure that the identified facilitating factors are sustained to increase the coverage of IPT to reach at least the minimum 50% as recommended by the WHO.References
References
Akolo, C., I. Adetifa, S. Shepperd & J. Volmink. (2010). Treatment of Latent Tuberculosis
Infection in HIV Infected Persons. Cochrane Database of Systematic Reviews, Issue 1. Art. No.:
CD000171.
Ayele, A.A., S. A. Atnafie, D..D Balcha, A.T. Weredekal, B.A. Woldegiorgis, €¦ & M.M.
Wotte. (2017). Self-Reported Adherence and Associated Factors to Isoniazid Preventive
Therapy for Latent Tuberculosis Among People Living With HIV/AIDS At Health
Centers in Gondar Town, North West Ethiopia.Patient Prefer Adherence, 11:743 €“9.
Berhe. M., M. Demissie, G. Tesfaye, M. Berhe, M. Demissie & G. Tesfaye. (2014).
Isoniazid Preventive Therapy Adherence and Associated Factors Among HIV Positive
Patients in Addis Ababa, Ethiopia. Advances in Epidemioly, 2014:1 €“6.
Conrad, K. B., L. Mteic, D. R. Brooksd, R. Waddelle, M. Bakaric, M. Mateec, €¦ & CRH.
(2014). Increased Mortality Associated With Treated Active Tuberculosis in HIVInfected Adults in Tanzania. NIH Public Access, 4(93):461 €“466.
Fusch, P. I. & Ness, L. R. (2015). Are We There Yet? Data Saturation in Qualitative Research.
(9), 1408 €“1416.
Ibrahim, M. (2012). Thematic Analysis : A Critical Review of Its Process and Evaluation. 1(1), 39 €“47.
Mesele Mindachew, Amare Deribew, Peter Memiah, S. B. (2014). Perceived Barriers to the
Implementation of Isoniazid Preventive Therapy for People Living With Hiv in Resource
Constrained Settings: A Qualitative Study. 8688, 1 €“6. https://doi.org/ 10.11604/ pamj.
17.26.2641.
Tanzania Commission for AIDS and Zanzibar AIDS Commission. (2018). Tanzania HIV
Impact Survey, (This) 2016-2017: Final Report. Dar es Salaam, Tanzania.
Getahun, H., R. Granich, D. Sculier, C. Gunneberg, L. Blanc, €¦ & P. Nunn. (2010).
Implementation of Isoniazid Preventive Therapy for People Living With HIV
Worldwide : Barriers and Solutions. AIDS, 24 (Suppl. 5):S57 €“S65.
Golub, J., V. Saraceni, C. Solange, P. Antonio, L. Moulton, €¦ & B. King. (2007). The
Impact of Antiretroviral Therapy and Isoniazid Preventive Therapy on Tuberculosis
Incidence in Hiv-Infected Patients in Rio De Janeiro, Brazil. AIDS,21(11):1441 €“8.
Habakkuk, A. Y., C. & F.N. Kuaban. (2011). Who Recommended Collaborative Tb/Hiv
Activities: Evaluation of Implementation and Performance in a Rural District Hospital
in Cameroon. Panafrican Medical Journal, 8688:4 €“9.
Lester, R., R. Hamilton, S. Charalambous, T. Dwadwa, C. Chandler, €¦ & G. J.
Churchyard. (2010). Barriers to Implementation of Isoniazid Preventive Therapy in HIV
Clinics: A Qualitative Study. AIDS, 24 (Suppl. 5):S45 €“S48.
Makanjuola, T., H.B. Taddese & A Booth. (2014). Factors Associated with Adherence to
Treatment with Isoniazid for the Prevention of Tuberculosis Amongst People Living
with HIV/AIDS: A Systematic Review of Qualitative Data. PLoS ONE. 9(2): e87166.
doi:10.1371/journal.pone.0087166.
Makoni, A., M. Chemhuru, M. Tshimanga, N.T. Gombe, M. Mungati & D. Bangure.
(2015). Evaluation of the Isoniazid Preventive Therapy (IPT) Program in Shurugwi
District, Midlands Province, Zimbabwe, January 2013 to August 2014. Bio Med Central
Research Notes, 8:476.